What is the appropriate management for a 59-year-old woman with chronic wood smoke exposure, presenting with left adventitious lung sounds, and a chest X-ray (CXR) showing dextroscoliosis, spondylolysis of the thoracic spine, and mild compression deformity of the lower thoracic vertebrae due to osteopenia or prior trauma?

From the Guidelines

The most appropriate management for this 59-year-old woman with chronic wood smoke exposure, presenting with left adventitious lung sounds, and a chest X-ray (CXR) showing dextroscoliosis, spondylolysis of the thoracic spine, and mild compression deformity of the lower thoracic vertebrae due to osteopenia or prior trauma is to reduce wood smoke exposure and assess for obstructive lung disease. I would order pulmonary function tests (PFTs) including spirometry with bronchodilator response to assess for obstructive lung disease, which is common with biomass fuel exposure, as suggested by the 2020 Chest Expert Panel report 1. I would also obtain a high-resolution CT scan of the chest to better evaluate for interstitial lung disease, bronchiectasis, or early emphysematous changes not visible on plain radiographs. For her respiratory symptoms, I would prescribe an inhaled bronchodilator such as albuterol 90mcg, 2 puffs every 4-6 hours as needed for shortness of breath, and consider a trial of inhaled corticosteroids like fluticasone 110mcg, 2 puffs twice daily if PFTs show obstruction. Regarding her thoracic spine findings, I would order a DEXA scan to evaluate bone mineral density given the compression deformities and possible osteopenia. Key considerations in her management include:

• Reducing wood smoke exposure by improving ventilation or transitioning to cleaner cooking methods, as chronic biomass fuel exposure is associated with chronic obstructive pulmonary disease, interstitial lung disease, and increased respiratory infections, as noted in the 2006 ACCP evidence-based clinical practice guidelines 1.
• Screening for hypoxemia with pulse oximetry and considering overnight oximetry to assess for nocturnal desaturation, which may require supplemental oxygen therapy if significant.
• Counseling on smoking cessation, if applicable, as smoking cessation and avoidance of exposure to environmental tobacco smoke at work and home are recommended, as stated in the 2013 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction 1.
• Considering referral to a smoking cessation program and the use of pharmacological agents including nicotine patches or gum, as recommended in the 2011 ACCF/AHA focused update incorporated into the ACC/aha 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction 1. Overall, a comprehensive approach addressing both her respiratory and musculoskeletal findings, along with reduction of wood smoke exposure, is crucial for improving her morbidity, mortality, and quality of life.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Diagnosis and Management

• The patient's symptoms and history of chronic wood smoke exposure suggest a potential respiratory condition, such as chronic obstructive pulmonary disease (COPD) 2.
• The chest X-ray (CXR) findings of dextroscoliosis, spondylolysis of the thoracic spine, and mild compression deformity of the lower thoracic vertebrae due to osteopenia or prior trauma may be contributing to the patient's respiratory symptoms 3.
• Spirometry is an essential clinical measurement for diagnosing and managing respiratory diseases, including COPD 2.
• High-resolution computed tomography (HRCT) scans can be used to evaluate the severity of COPD and correlate with pulmonary function tests 3, 4.
• The patient's left adventitious lung sounds and CXR findings suggest the need for further evaluation and management of their respiratory condition.

Pulmonary Function Testing

• Spirometry, including forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC), can be used to assess lung function and diagnose COPD 2, 5.
• HRCT scans can be used to evaluate the extent of emphysema and correlate with pulmonary function tests 3, 4.
• Other pulmonary function tests, such as impulse oscillometry and multiple breath nitrogen washout tests, may be useful in detecting small airway involvement and early disease detection 5, 6.

Management Considerations

• The patient's symptoms and history of chronic wood smoke exposure suggest the need for management of their respiratory condition, including potential pharmacological and non-pharmacological interventions 2, 6.
• The patient's CXR findings and potential osteopenia or prior trauma may require additional management considerations, such as physical therapy or orthopedic evaluation.
• Further evaluation and management of the patient's respiratory condition should be guided by the results of pulmonary function testing and HRCT scans 3, 4, 5.